Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
Clinical trial NCT01612039 · COMPLETED
Trial details
- NCT number
- NCT01612039
- Sponsor
- Telsar Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-04-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.